Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1

Status

Completed 3Terminated 1Suspended 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Dermatologic 3Breast 3Lymphoid 2CNS 2Thoracic 1Sarcoma 1Other hematologic neoplasm 1Head & Neck 1Genitourinary 1

Conditions

Breast Neoplasms 3Pain 1Neoplasm Metastasis 1Humoral Hypercalcemia Of Malignancy 1Breast Neoplasms, Male 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Antibodies, Monoclonal × Breast × Clear all
NCT03112590 2023-04-19

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Completed
51 enrolled 13 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00681993 2019-01-22

PBIC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
35 enrolled
Breast

Breast Neoplasms

NCT00060138 2013-05-15

Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases

Chugai Pharmaceutical

Phase 1/2 Completed
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡